| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A portion of amino acids 91-209 was used as the immunogen for the Fibroblast Growth Factor 21 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
Fibroblast Growth Factor 21 Antibody / FGF21 is an antibody targeting Fibroblast. Host: Mouse. Monoclonal. Clone: FGF21/4343. Format: Purified. Applications: IHC-P.
Key elements and design rationale
- Target: Fibroblast.
- Immunogen: A portion of amino acids 91-209 was used as the immunogen for the Fibroblast Growth Factor 21 antibody..
- Species reactivity: Human.
- Localization: Secreted (extracellular).
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
Fibroblast growth factor 21 is a protein that in humans is encoded by the FGF21 gene, a member of the fibroblast growth factor(FGF) family. FGF21 stimulates glucose uptake in adipocytes but not in other cell types.
Common research applications
- IHC: tissue distribution assessment; interpret with matched controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
